KYLEENA

This brand name is authorized in United States. It is also authorized in Australia, Austria, Brazil, Canada, Estonia, Finland, France, Ireland, Israel, Lithuania, Netherlands, Poland, South Africa, Spain, UK.

Active ingredients

The drug KYLEENA contains one active pharmaceutical ingredient (API):

1
UNII 5W7SIA7YZW - LEVONORGESTREL
 

The precise mode of action of levonorgestrel as an emergency contraceptive is not known. At the recommended regimen, levonorgestrel is thought to work mainly by preventing ovulation and fertilisation if intercourse has taken place in the preovulatory phase, when the likelihood of fertilisation is the highest.

 
Read more about Levonorgestrel

Medication package inserts

Below package inserts are available for further reading:

Document Type Information Source  
 KYLEENA Intrauterine delivery system (IUS) MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
G02BA03 Plastic IUD with progestogen G Genito urinary system and sex hormones → G02 Other gynecologicals → G02B Contraceptives for topical use → G02BA Intrauterine contraceptives
Discover more medicines within G02BA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
AU Pharmaceutical Benefits Scheme 11909T
BR Câmara de Regulação do Mercado de Medicamentos 538920010029707
CA Health Products and Food Branch 02459523
EE Ravimiamet 1703955, 1703966
ES Centro de información online de medicamentos de la AEMPS 81418
FI Lääkealan turvallisuus- ja kehittämiskeskus 098089
FR Base de données publique des médicaments 63463104
GB Medicines & Healthcare Products Regulatory Agency 350589
IE Health Products Regulatory Authority 33483
IL מִשְׂרַד הַבְּרִיאוּת 8396
LT Valstybinė vaistų kontrolės tarnyba 1078678, 1081935
NL Z-Index G-Standaard, PRK 141836
PL Rejestru Produktów Leczniczych 100358388, 100424748, 100436830, 100447382, 100454476
US FDA, National Drug Code 50419-424
ZA Health Products Regulatory Authority 47/32.9/0037

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.